Glaxosmithkline Pharmaceuticals informs about issuance of duplicate certificates

17 Jan 2020 Evaluate

Glaxosmithkline Pharmaceuticals has informed that pursuant to Regulation 39 and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), the Registrar and Transfer Agent of Company Karvy Fintech has received requests for issue of duplicate Share Certificates from Shareholder.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2543.10 33.80 (1.35%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×